Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
US-2024252425-A1 · Aug 1, 2024 · US
US11911503B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11911503-B2 |
| Application number | US-202117225634-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 8, 2021 |
| Priority date | Nov 20, 2012 |
| Publication date | Feb 27, 2024 |
| Grant date | Feb 27, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A process for the manufacture of semi-plastic pharmaceutical unit doses using a rotary moulding machine and semi-plastic pharmaceutical dosage units obtained by this process.
Opening claim text (preview).
What is claimed is: 1. A soft chewable veterinary pharmaceutical product for oral administration, wherein the soft chewable veterinary pharmaceutical product is obtainable by a process wherein the soft chewable veterinary pharmaceutical product is formed with a rotary moulding machine, comprising the steps of: a) mixing at least one active pharmaceutical ingredient with one or more components wherein the components are dry components and liquid components to prepare a premix, b) heating a polyethylene glycol forming agent until melting, c) mixing the premix and the polyethylene glycol forming agent together to form a dough, d) feeding the dough into a container connected with a rotary moulding machine; and e) forming a soft chewable veterinary pharmaceutical product for oral administration in a rotary moulding machine, wherein the liquid component comprises one or more oils and the polyethylene glycol forming agent is solid at room temperature and has a melting point between 45° C. and 100° C.; wherein the temperature of the dough in step d) is between 35° C. and 45° C.; and wherein the rotary moulding machine does not have a knockoff mechanism or a punch mechanism; wherein the active pharmaceutical ingredient is 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoro-ethylcarbamoyl)-methyl]-benzamide; and wherein the soft chewable veterinary pharmaceutical product has concave edges and has a weight of about 2 g or less or has a weight of more than about 10 g. 2. The soft chewable veterinary pharmaceutical product for oral administration according to claim 1 , wherein soft chewable veterinary pharmaceutical product is of cylindrical form. 3. A method of controlling a parasitic insect, acarid or nematode infestation of an animal comprising administering to the animal an effective amount of the soft chewable veterinary pharmaceutical product for oral administration of claim 1 .
containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465) · CPC title
Antiparasitic agents · CPC title
Oxazoles · CPC title
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals · CPC title
Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.